They modulate the TNF-α signaling via direct and indirect effects on the tumor microenvironment [121], and they reduce the secretion of FGF-2 [112], VEGF and IL-6 by both MM cells and BMSCs [59]. This evidence concerns the gene VEGFA and Miyoshi myopathy.